ATE446387T1 - Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie - Google Patents

Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie

Info

Publication number
ATE446387T1
ATE446387T1 AT04782716T AT04782716T ATE446387T1 AT E446387 T1 ATE446387 T1 AT E446387T1 AT 04782716 T AT04782716 T AT 04782716T AT 04782716 T AT04782716 T AT 04782716T AT E446387 T1 ATE446387 T1 AT E446387T1
Authority
AT
Austria
Prior art keywords
dot1
target
against leukemia
histone methyltransferases
therapeutics against
Prior art date
Application number
AT04782716T
Other languages
English (en)
Inventor
Yi Zhang
Qin Feng
Yuki Okada
Guoliang Xu
Original Assignee
Univ North Carolina
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ North Carolina filed Critical Univ North Carolina
Application granted granted Critical
Publication of ATE446387T1 publication Critical patent/ATE446387T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/10Transferases (2.)
    • C12N9/1003Transferases (2.) transferring one-carbon groups (2.1)
    • C12N9/1007Methyltransferases (general) (2.1.1.)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/136Screening for pharmacological compounds
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00Oligonucleotides characterized by their use
    • C12Q2600/154Methylation markers
AT04782716T 2004-08-31 2004-08-31 Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie ATE446387T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US2004/028289 WO2006025832A1 (en) 2004-08-31 2004-08-31 Dot1 histone methyltransferases as a target for identifying therapeutic agents for leukemia

Publications (1)

Publication Number Publication Date
ATE446387T1 true ATE446387T1 (de) 2009-11-15

Family

ID=36000364

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04782716T ATE446387T1 (de) 2004-08-31 2004-08-31 Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie

Country Status (6)

Country Link
EP (1) EP1791973B1 (de)
AT (1) ATE446387T1 (de)
DE (1) DE602004023766D1 (de)
DK (1) DK1791973T3 (de)
ES (1) ES2335411T3 (de)
WO (1) WO2006025832A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006336552B2 (en) 2006-01-20 2012-12-20 The University Of North Carolina At Chapel Hill Diagnostic and therapeutic targets for leukemia
AU2013312319B2 (en) 2012-09-06 2018-04-19 Epizyme, Inc. Method of treating leukemia
EP2970135B1 (de) 2013-03-14 2018-07-18 Epizyme, Inc. Pyrazolderivate als prmt1 inhibitoren und ihre verwendung
WO2014153214A1 (en) 2013-03-14 2014-09-25 Epizyme, Inc. Arginine methyl transferase inhibtors and uses thereof
WO2014153235A2 (en) 2013-03-14 2014-09-25 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
EP2970133B1 (de) 2013-03-14 2018-10-24 Epizyme, Inc. Pyrazolderivate als prmt1-inhibitoren und verwendungen davon
SG11201506972PA (en) 2013-03-14 2015-10-29 Epizyme Inc Arginine methyltransferase inhibitors and uses thereof
US9120757B2 (en) 2013-03-14 2015-09-01 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
EP2970181B1 (de) 2013-03-14 2017-06-07 Epizyme, Inc. Argininmethyltransferaseinhibitoren und verwendungen davon
JP2016518336A (ja) 2013-03-14 2016-06-23 エピザイム,インコーポレイティド Prmt1阻害剤としてのピラゾール誘導体およびその使用
US20160031839A1 (en) 2013-03-14 2016-02-04 Epizyme, Inc. Arginine methyltransferase inhibitors and uses thereof
US9776972B2 (en) 2013-03-14 2017-10-03 Epizyme Inc. Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
EP3180348A4 (de) * 2014-08-08 2018-02-07 Baylor College of Medicine Dot1l inhibitoren und deren verwendungen
CN108997480B (zh) * 2018-07-02 2021-07-27 中山大学附属第五医院 一种具有抑制组蛋白甲基化酶dot1l二甲基化活性的多肽、抑制剂及其设计方法与应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5420328A (en) 1992-09-11 1995-05-30 Affymax Technologies, N.V. Methods for the synthesis of phosphonate esters
US5288514A (en) 1992-09-14 1994-02-22 The Regents Of The University Of California Solid phase and combinatorial synthesis of benzodiazepine compounds on a solid support
US5525734A (en) 1994-06-22 1996-06-11 Affymax Technologies N.V. Methods for synthesizing diverse collections of pyrrolidine compounds
US5525735A (en) 1994-06-22 1996-06-11 Affymax Technologies Nv Methods for synthesizing diverse collections of pyrrolidine compounds
US5817751A (en) 1994-06-23 1998-10-06 Affymax Technologies N.V. Method for synthesis of diketopiperazine and diketomorpholine derivatives
AU2002329784A1 (en) * 2001-08-17 2003-03-03 Incyte Genomics, Inc. Molecules for disease detection and treatment

Also Published As

Publication number Publication date
WO2006025832A1 (en) 2006-03-09
EP1791973A1 (de) 2007-06-06
EP1791973A4 (de) 2008-01-23
DE602004023766D1 (de) 2009-12-03
ES2335411T3 (es) 2010-03-26
EP1791973B1 (de) 2009-10-21
DK1791973T3 (da) 2010-01-25

Similar Documents

Publication Publication Date Title
ATE446387T1 (de) Dot1-histon-methyltransferasen als ziel zur identifizierung von therapeutika gegen leukämie
WO2005073408A3 (en) Small segments of dna determine animal identity and source
ATE541054T1 (de) Bio-barcode erkennung für zielmoleküle
ATE431854T1 (de) Auf bio-barcodes beruhender nachweis von zielanalyten
ATE553216T1 (de) Sonden, bibliotheken und kits zur analyse von nukleinsäuregemischen und verfahren zu deren konstruktion
ATE548469T1 (de) Verfahren zur identifizierung mehrerer mutationen oder methylierungsmarkern in einem dominierenden hintergrund von wildtyp-dna
ATE468537T1 (de) Neurodegenerative marker für depression.
ATE525482T1 (de) Nanoreporter und verfahren zu deren herstellung und verwendung
KR100711046B1 (ko) 대장암에 대한 마커로서의 니코틴아미드n―메틸트랜스퍼라아제의 용도
CY1111229T1 (el) Μεθοδος προσδιορισμου ρευματοειδους αρθριτιδας με μετρηση αντι-ccp και ιντερλευκλινης 6
ATE397251T1 (de) Verfahren für das entwerfen von kleinen erythropoietin mimetika
WO2005114218A3 (en) Cross-screening system and methods for detecting a molecule having binding affinity for a target molecule
WO2010033452A3 (en) Mono-and multi-element coded libs assays and methods
ATE504833T1 (de) Verfahren zur bestimmung des phänotyps von zellen
BRPI0607016A2 (pt) marcadores polipeptìdicos para o diagnóstico de cáncer de próstata
MX2007004068A (es) Placa micro-estampada con micro-tarimas para analisis bioquimico direccionable.
WO2005032347A3 (en) Determining the chemosensitivity of cells to cytotoxic agents
ATE426168T1 (de) Verwendung von asc als marker fur kolorektalkarzinome
ATE414701T1 (de) Fluoreszenzsonden zur verwendung bei einem bindungsassay auf proteinkinaseinhibitoren
DE602007004570D1 (de) Verwendung von Nogo-C bei der Beurteilung von Herzversagen
WO2007127002A3 (en) Protein markers of responsiveness to type iii receptor tyrosine kinase inhibitors
DK1381696T3 (da) Methods
WO2007066129A3 (en) A method of detecting skeletal muscle damage
WO2003071252A3 (en) Methods for analysis of molecular events
DE60327776D1 (de) Sonden zum nachweis von tumorzellen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties